Growth Metrics

Volitionrx (VNRX) Operating Leases (2019 - 2025)

Volitionrx posted quarterly Operating Leases of $276558.0 for Q4 2025, down 56.27% year-on-year from $632441.0 in Q4 2024, and down 21.26% on a QoQ basis from $351211.0 in Q3 2025.

Volitionrx (VNRX) has 7 years of Operating Leases data on file, last reported at $276558.0 in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 56.27% year-over-year to $276558.0; the trailing twelve-month figure through Dec 2025 stood at $276558.0 (down 56.27% YoY), and the FY2025 full-year result was $276558.0, down 56.27% from the prior year.
  • Operating Leases for Q4 2025 stood at $276558.0, down from $351211.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $843443.0 in Q1 2022 and bottomed at $143998.0 in Q3 2021.
  • The 5-year median for Operating Leases is $378054.0 (2023), against an average of $402495.6.
  • The widest annual swing landed in 2022, when Operating Leases soared 358.39%; it then sank 56.27% in 2025.
  • A 5-year view of Operating Leases shows it stood at $217305.0 in 2021, then soared by 84.11% to $400091.0 in 2022, then fell by 5.51% to $378054.0 in 2023, then surged by 67.29% to $632441.0 in 2024, then tumbled by 56.27% to $276558.0 in 2025.
  • The last three Operating Leases figures came in at $276558.0 (Q4 2025), $351211.0 (Q3 2025), and $417015.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 276,558.00
Sep 30, 2025 351,211.00
Jun 30, 2025 417,015.00
Mar 31, 2025 369,342.00
Dec 31, 2024 632,441.00
Sep 30, 2024 448,045.00
Jun 30, 2024 350,810.00
Mar 31, 2024 396,376.00
Dec 31, 2023 378,054.00
Sep 30, 2023 323,957.00
Jun 30, 2023 340,314.00
Mar 31, 2023 381,722.00
Dec 31, 2022 400,091.00
Sep 30, 2022 449,326.00
Jun 30, 2022 761,323.00
Mar 31, 2022 843,443.00
Dec 31, 2021 217,305.00
Sep 30, 2021 143,998.00
Jun 30, 2021 166,085.00
Dec 31, 2020 179,624.00
Mar 31, 2020 112,209.00
Dec 31, 2019 131,875.00
Sep 30, 2019 90,270.00
Jun 30, 2019 110,630.00
Mar 31, 2019 110,630.00